Reply to Neutrophil-To-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710

Cancer - United States
doi 10.1002/cncr.30871
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pretreatment Neutrophil-To-Lymphocyte Ratio (NLR) and Platelet-To-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer

Scientific Reports
Multidisciplinary
2019English

Predictive Value of Neutrophil-To-Lymphocyte Ratio in Diabetic Wound Healing

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

Erciyes Medical Journal
Medicine
2019English

Prognostic Value of Neutrophil‐to‐lymphocyte Ratio and Platelet‐to‐lymphocyte Ratio for Breast Cancer Patients: An Updated Meta‐analysis of 17079 Individuals

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Prognostic Value of the Pretreatment Neutrophil-To-Lymphocyte Ratio in Cervical Cancer: A Meta-Analysis and Systematic Review

Oncotarget
Oncology
2017English

Prognostic Significance of Neutrophil-To-Lymphocyte Ratio in Rectal Cancer: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2016English

Prognostic Role for Derived Neutrophil-To-Lymphocyte Ratio in Early Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2016English

Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Plateletto- Lymphocyte Ratio in Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy